首页> 外国专利> COMPOSITIONS COMPRISING VITAMIN K FOR PREVENTING HYPERTENSION, LEFT VENTRICULAR HYPERTROPHY, CONGESTIVE HEART FAILURE, MYOCARDIAL INFARCTION, STROKE AND CORONARY HEART DISEASE BY PREVENTING AGE-RELATED STIFFENING OF ARTERIES

COMPOSITIONS COMPRISING VITAMIN K FOR PREVENTING HYPERTENSION, LEFT VENTRICULAR HYPERTROPHY, CONGESTIVE HEART FAILURE, MYOCARDIAL INFARCTION, STROKE AND CORONARY HEART DISEASE BY PREVENTING AGE-RELATED STIFFENING OF ARTERIES

机译:包含维生素K的成分,可预防与年龄相关的动脉硬化,从而预防高血压,左心室肥厚,心功能不全,心肌梗塞,中风和冠心病

摘要

Vitamin K is effective in counteracting cardiovascular disorders such as the reduction in arterial elasticity normally associated with the aging process. A pharmaceutical composition or nutritional formulation comprising vitamin K can be used to combat age-related stiffening of the arteries, and the consequences thereof, namely pulmonary congestion, hypertension, left ventricular hypertrophy, congestive (right sided) heart failure, left sided or left ventricular failure, chronic cardiac failure, angina pectoris, myocardial infarction, Mönckeberg's sclerosis and stroke. In various embodiments, vitamin K can also be used to reduce or reverse calcification of a blood vessel in pre-existing cardiovascular disorders such as arteriosclerosis.
机译:维生素K可有效抵抗心血管疾病,例如通常与衰老过程相关的动脉弹性降低。包含维生素K的药物组合物或营养制剂可用于对抗与年龄相关的动脉僵硬及其后果,即肺充血,高血压,左心室肥大,充血(右侧)心力衰竭,左侧或左侧心室衰竭,慢性心力衰竭,心绞痛,心肌梗塞,孟克伯格的硬化症和中风。在各种实施方案中,维生素K还可以用于减少或逆转先前存在的心血管疾病例如动脉硬化的血管钙化。

著录项

  • 公开/公告号EP1556025B1

    专利类型

  • 公开/公告日2011-02-23

    原文格式PDF

  • 申请/专利权人 NATTOPHARMA ASA;

    申请/专利号EP20030790959

  • 发明设计人 VERMEER CEESVITAK BV;

    申请日2003-09-01

  • 分类号A61K31/122;A61K31/593;A61P9/04;A61P9/10;A61P9/12;A61P9/14;

  • 国家 EP

  • 入库时间 2022-08-21 17:59:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号